Bullet Sensors & Transducers e-Digest, Vol. 150, Issue 3, March 2013: Business News

    (ISSN 1726-5479)

 

 

Editorial Calendar 2013

Editorial Board

Submit an Article

Submit a White Paper

Submit Press Release

Best Selling Articles 2012

Top 25 Downloaded Article

10 Top Sensors Products of 2012

Best_Articles_2011

Sensors & Transducers Journal 2011

Journal Subscription

ISSYS logo

 

 

Submit Press Release

 

or / and

 

White Paper

2000-2002 S&T e-Digest Contents

2003 S&T e-Digest Contents

2004 S&T e-Digest Contents

2005 S&T e-Digest Contents

2006 S&T e-Digest Contents

2007 S&T e-Digest Contents

2008 S&T e-Digest Contents

2009 S&T e-Digest Contents

2010 S&T e-Digest Contents

2011 S&T e-Digest Contents


 

 

ISSYS Inc. Awarded a Patent for Wireless, Implantable Hemodynamic Pressure Monitor (IHM) for Chronic Monitoring of Cardiovascular Diseases

 

 

Ypsilanti, Michigan, March 19, 2013 - Integrated Sensing Systems, Inc. (ISSYS) announced that the U.S Patent Office has granted a patent entitled "Method for Monitoring a Physiologic Parameter of Patients with Congestive Heart Failure" (US Patent No. 8,014,865). This patent covers miniature, wireless, batteryless, implantable hemodynamic sensors that are anchored within the heart for non-invasive monitoring of cardio physiological hemodynamic parameters, such as pressure, in order to provide advanced chronic patient management.

ISSYS' wireless, batteryless, sensor and anchor are delivered either via a catheter in an outpatient procedure or as an adjunct device during an already-establish procedure such as coronary artery bypass graft (CABG). The biocompatible anchor allows the miniature telemetric sensor to be stabilized within the heart and monitor left side of the heart (either left atrium or left ventricle). This is a very difficult task due to the stringent biocompatibility requirements of the left heart.

Dr. Nader Najafi, ISSYS CEO, stated that "The particular targets of ISSYS products are cardiovascular disease, especially congestive heart failure (CHF). This patent further expands the use of these miniature implants with other devices such as pacemakers, implantable cardioverter defibrillators (ICD's), and drug delivery products. ISSYS implants will facilitate monitoring patients' pressure in ICUs, medical facilities and at home. ISSYS plans to start its cardiovascular clinical studies in 2013. ISSYS' intellectual properties (patents, know how, and trade secrets) cover a wide spectrum including MEMS pressure sensors, wireless systems, delivery and anchoring for a variety of medical applications. In addition, ISSYS expanded its ISO 13485 certified manufacturing facility to produce tens of thousands of these miniature medical implants per year."

 

 

About ISSYS

 

ISSYS is a leader in advanced MEMS technologies for industrial, medical, microfluidic and scientific analytical sensing applications. Founded in 1995, ISSYS is one of the oldest independent MEMS companies in the US. ISSYS operates a comprehensive, state-of-the-art MEMS fabrication facility located near Ann Arbor, Michigan. ISSYS is currently registered to ISO 9001:2008, EN13980:2002 for its ATEX (intrinsically safe products), and ISO13485:2003 standard for Class III medical devices. ISSYS is a vertically integrated company dedicated to developing and manufacturing system-level products based on MEMS technology (MEMS Inside), please visit: http://www.mems-issys.com/

 

 

 

 

 

Contact:

 

Nader Najafi, Ph.D.

Integrated Sensing Systems Inc. (ISSYS)

391 Airport Industrial Dr., Ypsilanti, MI 48198

Tel.: (734) 547-9896 Ext. 103

Fax: (734) 547-9964

E-mail: nader@mems-issys.com

Web: http://www.mems-issys.com/

 

 

Handbook of Laboratory Measurements

 

 

Back to S&T e-Digest page

 


1999 - 2013 Copyright , International Frequency Sensor Association (IFSA). All Rights Reserved.